...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.
【24h】

Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.

机译:使用基于阵列的比较基因组杂交技术分析卵巢癌细胞系。

获取原文
获取原文并翻译 | 示例

摘要

In this study, 23 ovarian cancer cell lines were screened using array-comparative genomic hybridization (aCGH) based on large-insert clones at about 1 Mb density from throughout the genome. The most frequent recurrent changes at the level of the chromosome arm were loss of chromosome 4 or 4q, loss of 18q and gain of 20 or 20q; other recurrent changes included losses of 6q, 8p, 9p, 11p, 15q, 16q, 17p, and 22q, and gain of 7q. Losses of 4q and 18q occurred together more often than expected. Evidence was found for two types of ovarian cancer, one typically near-triploid and characterized by a generally higher frequency of chromosomal changes (especially losses of 4p, 4q, 13q, 15q, 16p, 16q, 18p and 18q), and the other typically near-diploid/tetraploid and with fewer changes overall, but with relatively high frequencies of 9p loss, 9q gain, and 20p gain. Multiple novel changes (amplifications, homozygous deletions, discrete regions of gain or loss, small overlapping regions of change and frequently changedclones) were also detected, each of which might indicate the locations of oncogenes or tumour suppressor loci. For example, at least two regions of amplification on chromosome 11q13, one including cyclin D1 and the other the candidate oncogene PAK1, were found. Amplification on 11q22 near the progesterone receptor gene and a cluster of matrix metalloproteinase loci was also detected. Other potential oncogenes, which mapped to regions found by this study, included cyclin E and PIK3C2G. Candidate tumour suppressor genes in regions of loss included CDKN2C, SMAD4-interacting protein and RASSF2.
机译:在这项研究中,使用基于阵列的基因组杂交(aCGH)筛选了23个卵巢癌细胞系,该杂交基于整个基因组中密度约为1 Mb的大插入克隆。在染色体臂水平上最频繁发生的周期性变化是第4或4q号染色体丢失,丢失18q和20或20q增益。其他经常性变化包括6q,8p,9p,11p,15q,16q,17p和22q的损失,以及7q的损失。 4q和18q的损失并发的可能性比预期的高。发现了两种类型的卵巢癌的证据,一种典型地接近三倍体,并且特征在于染色体变化的频率通常更高(尤其是损失4p,4q,13q,15q,16p,16q,18p和18q),而另一种典型地接近二倍体/四倍体,总体变化较小,但频率较高,分别为9p损耗,9q增益和20p增益。还检测到多个新的变化(扩增,纯合缺失,离散的增益或缺失区域,较小的变化重叠区域和频繁变化的克隆),每个变化都可能指示癌基因或肿瘤抑制基因座的位置。例如,在染色体11q13上发现了至少两个扩增区域,一个包含细胞周期蛋白D1,另一个包含候选癌基因PAK1。还检测到孕酮受体基因附近的11q22扩增和基质金属蛋白酶基因座簇。定位到该研究发现的区域的其他潜在致癌基因包括细胞周期蛋白E和PIK3C2G。缺失区域的候选肿瘤抑制基因包括CDKN2C,SMAD4相互作用蛋白和RASSF2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号